Agtc Jobs | Glassdoor Search Agtc jobs. Get the right Agtc job with company ratings & salaries. 11 open jobs for Agtc. Applied Genetic (AGTC) Financial Summary - Investing.com UK Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for
Nov 06, 2019 · Applied Genetic Technologies Corp. company facts, information and stock details by MarketWatch. View agtc business summary and other industry information.
AGTC Forum. Joining the Conversation. Stock discussion forums can often be a place of loud opinions and little merit. To help users find value, the Tradescores forum requires participants to hold an open and filled position, either long or short, in the stock they are discussing. Their position and performance metrics for that trade are AGTC Applied Genetic Technologies Corp. Stock Message Board Applied Genetic Technologies Corp. engages in the development of gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases. It has clinical trials in the field of ophthalmology, optogenetics, adrenoleukodystrophy, and otology. The company was founded by Richard Jude Samulski, Nicholas Muzyczka, William W. Hauswirth, Terence … AGTC stock: Applied Genetic Technologies C
Applied Genetic Technologies (AGTC): Gene Therapy for Opthalmology AGTC Stock. AGTC went public in 2014, raising $57.5 million in gross proceeds at a post-IPO valuation of $168 million
(International Forum for Rural Transport and Development). 10 World Economic Forum 2013. structuring the space, and taking stock of targets and bined Transport Lines and Related Installations (AGTC), d) The European Agreement. 10. Jan. 2020 Applied Genetic Technologies (AGTC): Biotech-Aktie Tagesgewinner mit Symbol: AGTC ISIN: US03820J1007 powered by stock-world.de.